[go: up one dir, main page]

BE606205A - Nouvelles compositions pharmaceutiques comprenant la 5-nitro-8-hydroxy-quinoléine ainsi que ses dérivés halogénés en position 7. - Google Patents

Nouvelles compositions pharmaceutiques comprenant la 5-nitro-8-hydroxy-quinoléine ainsi que ses dérivés halogénés en position 7.

Info

Publication number
BE606205A
BE606205A BE606205A BE606205A BE606205A BE 606205 A BE606205 A BE 606205A BE 606205 A BE606205 A BE 606205A BE 606205 A BE606205 A BE 606205A BE 606205 A BE606205 A BE 606205A
Authority
BE
Belgium
Prior art keywords
quinoline
nitro
hydroxy
well
pharmaceutical compositions
Prior art date
Application number
BE606205A
Other languages
English (en)
Original Assignee
Docteur Debat Lab De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Docteur Debat Lab De filed Critical Docteur Debat Lab De
Publication of BE606205A publication Critical patent/BE606205A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
BE606205A 1960-07-15 1961-07-17 Nouvelles compositions pharmaceutiques comprenant la 5-nitro-8-hydroxy-quinoléine ainsi que ses dérivés halogénés en position 7. BE606205A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2473660 1960-07-15

Publications (1)

Publication Number Publication Date
BE606205A true BE606205A (fr) 1961-11-16

Family

ID=39319895

Family Applications (1)

Application Number Title Priority Date Filing Date
BE606205A BE606205A (fr) 1960-07-15 1961-07-17 Nouvelles compositions pharmaceutiques comprenant la 5-nitro-8-hydroxy-quinoléine ainsi que ses dérivés halogénés en position 7.

Country Status (2)

Country Link
BE (1) BE606205A (fr)
FR (1) FR1271M (fr)

Also Published As

Publication number Publication date
FR1271M (fr) 1962-04-24

Similar Documents

Publication Publication Date Title
FR1320M (fr) Agents pharmaceutiques a base de benzenedisulfamides.
FR2144M (fr) Compositions pharmaceutiques contenant des sources radioactives.
FR3195M (fr) Compositions pharmaceutiques comprenant des dérivés de thébaine.
FR1715M (fr) Composition thérapeutique.
BE606205A (fr) Nouvelles compositions pharmaceutiques comprenant la 5-nitro-8-hydroxy-quinoléine ainsi que ses dérivés halogénés en position 7.
BE603407A (fr) Dérivés d'acrylamide de dialdéhyde-polysaccharides.
FR1443M (fr) Préparation dermatologique.
FR1045M (fr) Compositions anorexigéniques.
BE599006A (fr) Complexe de Werner et sa préparation.
FR3054M (fr) Préparations pharmaceutiques.
FR2057M (fr) Compositions pharmaceutiques a base de dérivés de la tétrahydro-isoquinoléine.
FR3376M (fr) Compositions pharmaceutiques contenant des dérivés de la quinoléine.
FR1007M (fr) Dérivés de la pipérazine utilisables comme médicaments.
BE619267A (fr) Dérivés d'algines dépolymérisées.
FR383M (fr) Dérivés d'anilinobenzoquinone.
FR1790M (fr) Dérivés d'aralcoylaminopyrimidines et leurs procédés de préparation.
FR1041M (fr) Nouvelles compositions pharmaceutiques contenant la 5-5-diphényltétrahydrogloxaline-4-one.
FR2954M (fr) Compositions aqueuses pharmaceutiques stérilisées in situ.
BE600340A (fr) Nouvelles 1.2-diaryl-3.5-dioxo-pyrazolidines substituées en position 4 et leur préparation.
BE600553A (fr) Nouvelles 1.2-diaryl-3.5-dioxo-pyrazolidines substituées en position 4 et leur préparation
FR1364M (fr) Dérivés de l'acridane.
BE585967A (fr) Compositions pharmaceutiques contenant des dérivés de la benzylhydrazine.
BE575518A (fr) Compositions pharmaceutiques à base d'alcopipéridines.
FR1600M (fr) Produits d'addition.
BE604996A (fr) Dérivés de la 1,2,3,4-tétrahydroquinazolinone et leur préparation